<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">531</article-id>
<article-id pub-id-type="doi">10.54660/IJMBHR.2026.7.3.246-250</article-id>
<title-group><article-title>Antimicrobial Resistance and Biofilm Formation among Clinical Staphylococcus aureus Isolates: A Cross-Sectional Study at a Tertiary Care Hospital in Northern India</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Kaushik</surname><given-names>Pradyuman</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Srinivas</surname><given-names>J</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Saxena</surname><given-names>Rati</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Wadhawan</surname><given-names>Bhanupriya</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<aff id="aff1"><label>1</label>Department of Microbiology, Rajshree Medical Research Institute, Bareilly, Uttar Pradesh, India</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><day>15</day><month>08</month><year>2026</year></pub-date>
<volume>7</volume>
<issue>3</issue>
<fpage>246</fpage>
<lpage>250</lpage>
<history>
<date date-type="received"><day>19</day><month>06</month><year>2026</year></date>
<date date-type="accepted"><day>17</day><month>07</month><year>2026</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/531/antimicrobial-resistance-and-biofilm-formation-among-clinical-staphylococcus-aureus-isolates-a"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/531/download"/>
<abstract><p>Background: Staphylococcus aureus remains one of the most important agents of community- and hospital-acquired infections, and its capacity to acquire antimicrobial resistance together with the ability to form biofilm poses a major therapeutic challenge. This study was undertaken to determine the antimicrobial resistance pattern and biofilm-forming ability of S. aureus isolated from clinical samples of patients attending a tertiary care hospital in Bareilly, Uttar Pradesh, India.
Methods: A hospital-based cross-sectional study was conducted in the Department of Microbiology, Rajshree Medical Research Institute, Bareilly. A total of 500 clinical samples received from indoor and outdoor patients were processed by standard microbiological methods. Antimicrobial susceptibility testing was performed by the Kirby–Bauer disc diffusion method as per CLSI guidelines, methicillin resistance was detected using the cefoxitin disc diffusion test, and biofilm production was assessed by the microtiter plate method.
Results: Of the 500 clinical samples processed, 59 (11.8%) yielded bacterial growth, of which 51 (86.4%) were identified as S. aureus. The isolates showed the highest resistance to penicillin and ampicillin (88.2% each), while all isolates (100%) remained sensitive to linezolid. Twenty-eight isolates (54.9%) were methicillin-resistant S. aureus (MRSA). Multidrug resistance (resistance to ≥3 antibiotic classes) was observed in 47 (92.2%) isolates. All 51 isolates produced biofilm in vitro, of which 13 (25.5%), 24 (47.1%), and 14 (27.5%) were weak, moderate, and strong biofilm producers, respectively. Strong biofilm producers retained the highest sensitivity to linezolid, gentamicin, and tetracycline.
Conclusion: A high prevalence of methicillin resistance, multidrug resistance, and biofilm production was observed among clinical S. aureus isolates in this tertiary care hospital. Linezolid, gentamicin, and tetracycline remain reliable therapeutic options. Regular antimicrobial surveillance and an institutional antibiotic stewardship programme are warranted to guide empirical therapy and curb the further spread of resistant strains.
 </p></abstract>
<kwd-group kwd-group-type="author"><kwd>Staphylococcus aureus</kwd><kwd>antimicrobial resistance</kwd><kwd>MRSA</kwd><kwd>biofilm</kwd><kwd>tertiary care hospital</kwd><kwd>Bareilly</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Ansari S, Nepal HP, Gautam R, Rayamajhi N, Shrestha S, Upadhyay G, et al. Threat of drug resistant Staphylococcus aureus to health in Nepal. BMC Infect Dis. 2014;14:157.</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Aslantaş Ö, Demir C. Investigation of the antibiotic resistance and biofilm-forming ability of Staphylococcus aureus from subclinical bovine mastitis cases. J Dairy Sci. 2016;99(11):8607.</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Belbase A, Pant ND, Nepal K, Neupane B, Baidhya R, Baidya R, et al. Antibiotic resistance and biofilm production among the strains of Staphylococcus aureus isolated from pus/wound swab samples in a tertiary care hospital in Nepal. Ann Clin Microbiol Antimicrob. 2017;16(1):15.</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Chatterjee A, Rai S, Guddattu V, Mukhopadhyay C, Saravu K. Is methicillin-resistant Staphylococcus aureus infection associated with higher mortality and morbidity in hospitalized patients? A cohort study of 551 patients from South Western India. Risk Manag Healthc Policy. 2018;11:243.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Chaudhary BL, Bisht D, Faujdar SS. Biofilm formation and its association with antibiotic susceptibility pattern in methicillin-resistant Staphylococcus aureus isolates. J Pure Appl Microbiol. 2021;15(4):2041.</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. 13th ed. CLSI standard M02. Wayne (PA): Clinical and Laboratory Standards Institute; 2018.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Derakhshan S, Navidinia M, Haghi F. Antibiotic susceptibility of human-associated Staphylococcus aureus and its relation to agr typing, virulence genes, and biofilm formation. BMC Infect Dis. 2021;21(1):627.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Duran N, Ozer B, Duran GG, Onlen Y, Demir C. Antibiotic resistance genes and susceptibility patterns in staphylococci. Indian J Med Res. 2012;135(3):389.</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Gaire U, Thapa Shrestha U, Adhikari S, Adhikari N, Bastola A, Rijal KR, et al. Antibiotic susceptibility, biofilm production, and detection of mecA gene among Staphylococcus aureus isolates from different clinical specimens. Diseases. 2021;9(4):80.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Gupta P, Gupta P, Mittal G, Agarwal RK, Goyal R. Detection of biofilm production in blood culture isolates of Staphylococci. Int J Med Res Health Sci. 2015;4(1):22.</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Islam MA, Uddin MS, Islam MJ, Ahmed MU, Alam MM. Investigation of antibiotic resistance pattern of Staphylococcus aureus in clinical samples of animals and humans from selective areas of Bangladesh. Bangl J Vet Med. 2021;19(1):9.</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Martínez SR, Rocca DM, Aiassa V, Becerra MC. Linezolid as an eradication agent against assembled methicillin-resistant Staphylococcus aureus biofilms. RSC Adv. 2016;6(103):101023.</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Mehta Y, Hegde A, Pande R, Zirpe KG, Gupta V, Ahdal J, et al. Methicillin-resistant Staphylococcus aureus in intensive care unit setting of India: a review of clinical burden, patterns of prevalence, preventive measures, and future strategies. Indian J Crit Care Med. 2020;24(1):55.</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Mottola C, Matias CS, Mendes JJ, Melo-Cristino J, Tavares L, Cavaco-Silva P, et al. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections. BMC Microbiol. 2016;16(1):119.</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Neopane P, Nepal HP, Shrestha R, Uehara O, Abiko Y. in vitro biofilm formation by Staphylococcus aureus isolated from wounds of hospital-admitted patients and their association with antimicrobial resistance. Int J Gen Med. 2018;11:25.</mixed-citation></ref>
<ref id="R16"><label>16</label><mixed-citation>Pappu RK, Kumar R, Poddar CK, Singh MN. Methicillin resistance Staphylococcus aureus isolated from surgical site infection in a tertiary care hospital, Koshi region (Northern Bihar), India. J Evid Based Med Healthc. 2020;7(19):927.</mixed-citation></ref>
<ref id="R17"><label>17</label><mixed-citation>Sapkota J, Sharma M, Jha B, Bhatt CP. Prevalence of Staphylococcus aureus isolated from clinical samples in a tertiary care hospital: a descriptive cross-sectional study. JNMA J Nepal Med Assoc. 2019;57(220):398.</mixed-citation></ref>
<ref id="R18"><label>18</label><mixed-citation>Stepanović S, Vuković D, Hola V, Di Bonaventura G, Djukić S, Cirković I, et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 2007;115(8):891.</mixed-citation></ref>
<ref id="R19"><label>19</label><mixed-citation>Tarai B, Das P, Kumar D. Recurrent challenges for clinicians: emergence of methicillin-resistant Staphylococcus aureus, vancomycin resistance, and current treatment options. J Lab Physicians. 2013;5(2):71.</mixed-citation></ref>
<ref id="R20"><label>20</label><mixed-citation>Weinstein MP, Lewis JS 2nd. The Clinical and Laboratory Standards Institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes. J Clin Microbiol. 2020;58(3):e01864-19.</mixed-citation></ref>
<ref id="R21"><label>21</label><mixed-citation>Wilson ML, Fleming KA, Kuti MA, Looi LM, Lago N, Ru K. Access to pathology and laboratory medicine services: a crucial gap. Lancet. 2018;391(10133):1927.</mixed-citation></ref>
<ref id="R22"><label>22</label><mixed-citation>Yılmaz EŞ, Aslantaş Ö. Antimicrobial resistance and underlying mechanisms in Staphylococcus aureus isolates. Asian Pac J Trop Med. 2017;10(11):1059.</mixed-citation></ref>
<ref id="R23"><label>23</label><mixed-citation>Young D, Hussell T, Dougan G. Chronic bacterial infections: living with unwanted guests. Nat Immunol. 2002;3(11):1026.</mixed-citation></ref>
</ref-list></back>
</article>